cadenas
  • Innovative Therapies
    for Children with Cancer in Europe
  • Contact us

ITCC-015 VIDAZA

A phase I/II study of Azacytidine (VIDAZA®) in pediatric patients with relapsed high-grade pediatric MDS or JMML

Promotor Name : CELGENE

Investigator Name : M. ZWAAN

Trial registered on clinicaltrial.gov : NCT02447666